middle.news
Rhythm Biosciences Unveils $3.75M Placement with 52.5M Options, Awaiting Shareholder Nod
1:01pm on Monday 18th of August, 2025 AEST
•
Healthcare
Read Story
Rhythm Biosciences Unveils $3.75M Placement with 52.5M Options, Awaiting Shareholder Nod
1:01pm on Monday 18th of August, 2025 AEST
Key Points
Placement to raise approximately $3.75 million at $0.09 per share
Up to 52.45 million new options offered with $0.20 exercise price
Options include nil-cost attaching options to investors and directors, plus 10.8 million to lead manager
Shareholder approval required for all option and share issuances
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Rhythm Biosciences (ASX:RHY)
OPEN ARTICLE